Oxitec Pioneered the GM Mosquito. Up Next? Moths, of Course
By Eric Niiler,
Wired
| 05. 10. 2017
A HALF-INCH-LONG MOTH that devours kale, broccoli, and Brussels sprouts may not inspire the same fear as a Zika-carrying mosquito, but the two insects have something in common. Both are being genetically tweaked by UK-based biotech firm Oxitec. Last year, the company made news when it proposed a Florida-based trial of a self-destructive mosquito—designed to stop the spread of Zika virus in native Aedes aegypti mosquitoes.
Now, Oxitec wants to test a genetically modified version of the male diamondback moth to mate with—and eventually destroy—a pest that damages $5 billion worth of cruciferous crops every year worldwide. Like the mosquito, the moth passed laboratory and greenhouse trials and now must pass approval in a open field test. But while the mosquito had to wind its way through the FDA, Oxitec’s moth faces a different set of regulatory hurdles at the USDA. Officials at that agency are currently reviewing whether to allow Cornell University and Oxitec to release tens of thousands of GM moths into a 10-acre site in New York.
For decades, agricultural researchers have battled insect pests that are growing...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...